Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Century Therapeutics, Inc. (IPSC)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
16 Feb 2024
Farid Adrienne
Chief Operations Officer, Officer
Century Therapeutics, Inc.
(IPSC)
114,149
-0%
485
$4.86
$2,358.26
SELL
5 Feb 2024
Carr Douglas
SVP Finance & Operations, Officer
Century Therapeutics, Inc.
(IPSC)
303,580
-0%
1,200
$4.14
$4,969.02
SELL
5 Feb 2024
Farid Adrienne
Chief Operations Officer, Officer
Century Therapeutics, Inc.
(IPSC)
114,149
-3%
3,819
$4.14
$15,821.24
SELL
21 Mar 2023
Borges Luis
Chief Scientific Officer, Officer
Century Therapeutics, Inc.
(IPSC)
249,083
-36%
144,911
$3.73
$539,879.50
SELL
9 Aug 2022
Versant Venture Capital VI, L.P.
10% Owner
Century Therapeutics, Inc.
(IPSC)
11,816,814
-4%
550,000
$13.03
$7,166,610.00
BUY
22 Jun 2021
Versant Venture Capital VI, L.P.
10% Owner
Century Therapeutics, Inc.
(IPSC)
714,095
+16%
100,000
$20.00
$2,000,000.00
BUY
22 Jun 2021
BAYER AKTIENGESELLSCHAFT
10% Owner
Century Therapeutics, Inc.
(IPSC)
12,675,838
+6%
750,000
$20.00
$15,000,000.00
BUY
22 Jun 2021
Casdin Eli
Director
Century Therapeutics, Inc.
(IPSC)
3,206,380
+30%
750,000
$20.00
$15,000,000.00
Home